Minoxidil a Youth Elixir for Eyebrow Hypotrichosis

Gajbhiye, Varsha; Lamture, Yashwant

doi:10.7860/jcdr/2020/42801.13474

Cited by 10 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In cases where there was no upgrade after the introduction of amblyopia treatment at two to three successive visits, the result of amblyopia needs to be re-evaluated, & reconsideration of the opposition status or diagnostic review may be needed [15][16][17][18][19][20][21].…”

Section: Occlu-pad or Occlu-tabmentioning

confidence: 99%

A Review on Management of Amblyopia

Kolhe

Diaghvane

2021

JPRI

View full text Add to dashboard Cite

Amblyopia is a visual cortex neurodevelopmental condition cause am vision abnormalities during childhood. It is one of the most typical causes of vision loss at an early age. It occurs due to abnormal development of the visual cortex. The part receiving signals from the diseased eye does not receive it correctly and thus develops abnormally. This abnormal development during the critical period of growth of child results in brain damage. Depending on its aetiology the types of amblyopia are Strabismic amblyopia, Visual deprivation amblyopia, Anisometric, Ametropic, Meridional, Toxic amblyopia. Clinical features are visual acuity is reduced, the effect of neutral density filter, the Crowding phenomenon is present. Complications of amblyopia include a Lazy eye becoming weak permanently, the eye may move out from the visual axis (squints). When treating amblyopia, our goal is that the eyes will work together in unison at an equal level; this will create a clear vision in the lazy eye. Amblyopia is treated in various ways depending on the seriousness of the disease and the patient's age. Patching of the non-amblyopic eye, as well as treatment with drugs like atropine, are common treatments. Vision therapy and some modifications to spectacles and contact lenses have been discovered to be effective in treating amblyopia in recent years. Modern Treatment- Falling Blocks, Occlu-pad. With current breakthroughs in amblyopia therapy, the success rate of a multimodal strategy is also improving. The purpose of this review article is to present information on the management of amblyopia. Literature on AMBLYOPIA MANAGEMENT has been taken from PubMed, Scopus, Science Direct, and other internet resources.

show abstract

Section: Occlu-pad or Occlu-tabmentioning

confidence: 99%

A Review on Management of Amblyopia

Kolhe

Diaghvane

2021

JPRI

View full text Add to dashboard Cite

show abstract

“…Up regulation of PGC-1 by various agents resulted in over expression of its related transcriptional factors, antioxidants, and mitochondrial genes, according to Saint-Geniez's research which in turn prolongs or increases the life of retinal cells [19]. Some of the studies suggest that the use of pluripotent stem cells (PSC) could be useful in the treatment of retinal disorders [20][21][22][23][24][25]. Pluripotent stem cells transplantation could therefore in near future help in treatment of retinal diseases including age related macular degeneration (ARMD) [20].…”

Section: Role Of Telomerasementioning

confidence: 99%

Review of Role of Telomerase in the Management of Age-related Macular Degeneration

Ranjan

Tidake

2021

JPRI

View full text Add to dashboard Cite

Age related macular degeneration is degenerative disorder, which is more prevalent in the Western, developed countries but can become a major threat in India as well. It affects the macula and leads to the senescence of retinal pigment epithelium. Most commonly affected is the central vision as macula is involved in central vision. On Optical Coherence Tomography (OCT) reduction in retinal epithelium can be seen along with accumulation of blood in the sub retinal space due to haemorrhage in the wet type of ARMD. It is a multifactorial disease and some of the major risk factors of this disease include sunlight exposure i.e. production of large amounts of reactive oxygen species (ROS), smoking, blue iris etc. It is more commonly seen in females and in Caucasians. It is of two major types which include the dry type (85%) and the remaining wet type. Wet type is characterised by neovascularisation whereas the dry type shown the presence of drusens and hyperpigmentation of the retina on examination. Clinical features of this disease include gradual loss of vision, but in wet type due to fragile vessels there occurs haemorrhage which can lead to sudden loss of vision. ARMD can be prevented by introduction of telomerase in the treatment line. Telomerases help in increasing the life span of RPE, thereby delaying the senescence of the retinal cells. Other treatment modalities also include the administration of lutein, xeathanthine, various antioxidants and anti-VEGF (vascular endothelium growth factor) medication. All these measures together can help in reducing the number of cases of ARMD and providing a better vision to the older population to increase the quality of life.

show abstract

“…Carbon Anhydrase inhibitors might have several adverse effects conjointly, together with a change in style, abdominal pain, diarrhea, fatigue, vomiting, symptom, and headache [11][12][13][14][15][16].…”

Section: Moa Of Element Anhydrase Inhibitors -mentioning

confidence: 99%

Therapeutic Role of Element Anhydrase Inhibitors in Treatment of Glaucoma: A Review

Kadu

Zilate

2021

JPRI

View full text Add to dashboard Cite

Eye disease may be a cluster of inveterately progressive disorders of the nervus opticus. during this article, I gift the medicine, Pathophysiology, risk factors, ophthalmic examination, and therapeutic role of carbonaceous anhydrase inhibitors in treating eye disease. In European countries, the prevalence of eye disease is a pair of.93% among persons aged 40-80 years, reaching ten you tired of persons over ninety years old-time. There is a unit many differing types of eye disease, and that they are classically divided into classes of open-angle and closed-angle eye disease. Use of topical selective or nonselective beta-blockers is used in the treatment of eye diseases. Second-line drugs of alternative embody alpha – agonists and topical carbonaceous anhydrase inhibitors. Parasympathomimetics drugs, most ordinarily alkaloid, area unit thought-about third-line treatment. For patients, the United Nations agency doesn't reply to antiglaucoma remedy, optical laser incisional and trabeculoplasty surgery area unit more ways that may be accustomed lower the pressure. The inhibitors area unit used medication in the treatment of symptom coronary failure, brain disease, and hypoxia conjointly. A Corollary of Friedenwald's construct of hydrogen carbonate secretion within the formation of liquid body substance is that inhibition of the protein carbonaceous anhydrase could be expected to decrease the speed of secretion and lower IOP. The carbonaceous anhydrase matter, Diamox (acetazolamide) is employed in the treatment of eye disease. Preliminary trials of Diamox in rabbits created a definite lowering of pressure to once ten to one hundred mg. carbonaceous anhydrase inhibitors diminish ocular high blood pressure in glaucomatous patients by reducing the hydrogen carbonate formation.

show abstract

Minoxidil a Youth Elixir for Eyebrow Hypotrichosis

Cited by 10 publications

References 0 publications

A Review on Management of Amblyopia

A Review on Management of Amblyopia

Review of Role of Telomerase in the Management of Age-related Macular Degeneration

Therapeutic Role of Element Anhydrase Inhibitors in Treatment of Glaucoma: A Review

Contact Info

Product

Resources

About